πŸ‡ΊπŸ‡Έ FDA
Patent

US 8815226

Protein-polymer-drug conjugates

granted A61KA61K47/58A61K47/59

Quick answer

US patent 8815226 (Protein-polymer-drug conjugates) held by Mersana Therapeutics, Inc. expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mersana Therapeutics, Inc.
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/58, A61K47/59, A61K47/60, A61K47/64